ERA-NET subsidy for translational research on human ovarian tumour
Peter Horvatovich, Analytical Biochemistry (Groningen Research institute of Pharmacy), received as consortium partner in TRANSCAN-2, ERA-NET research program 300.000 euro subsidy for translational research on human ovarian tumour heterogeneity to overcome recurrence and resistance to therapy. The project in collaboration with European partners and the labs of Kathrin Thedieck (UMCG), Marco Grzegorczyk (JBI) and Victor Guryev (UMCG) will allow to understand molecular heterogeneity of human primary and metastatic ovarian cancer and open new doors for better patient characterization and personalized treatment of this malignant cancer type, where patients have currently less than 45% of 5-years survival rate.
| Last modified: | 07 April 2016 11.41 a.m. |
More news
-
16 April 2024
UG signs Barcelona Declaration on Open Research Information
In a significant stride toward advancing responsible research assessment and open science, the University of Groningen has officially signed the Barcelona Declaration on Open Research Information.
-
02 April 2024
Flying on wood dust
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
18 March 2024
VentureLab North helps researchers to develop succesful startups
It has happened to many researchers. While working, you suddenly ask yourself: would this not be incredibly useful for people outside of my own research discipline? There are many ways to share the results of your research. For example, think of a...